Thomas K. Equels - 12 Jun 2025 Form 4 Insider Report for AIM ImmunoTech Inc. (AIM)

Signature
/s/ Thomas K Equels
Issuer symbol
AIM
Transactions as of
12 Jun 2025
Net transactions value
+$896
Form type
4
Filing time
13 Jun 2025, 11:04:18 UTC
Previous filing
23 Apr 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Equels Thomas K CEO & President, Director 2117 SOUTHWEST HIGHWAY 484, OCALA /s/ Thomas K Equels 13 Jun 2025 0001450324

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AIM Common Stock Purchase $896 +103 +0.27% $8.70* 38,675 12 Jun 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.